Sodium oligomannate disrupts the adherence of Ribhigh bacteria to gut epithelia to block SAA-triggered Th1 inflammation in 5XFAD transgenic mice
- PMID: 39557828
- PMCID: PMC11573985
- DOI: 10.1038/s41421-024-00725-5
Sodium oligomannate disrupts the adherence of Ribhigh bacteria to gut epithelia to block SAA-triggered Th1 inflammation in 5XFAD transgenic mice
Abstract
Sodium oligomannate (GV-971), an oligosaccharide drug approved in China for treating mild-to-moderate Alzheimer's disease (AD), was previously found to recondition the gut microbiota and limit altered peripheral Th1 immunity in AD transgenic mice. As a follow-up study, we here made advances by pinpointing a Lactobacillus murinus (L.m.) strain that highly expressed a gene encoding a putative adhesin containing Rib repeats (Ribhigh-L.m.) particularly enriched in 5XFAD transgenic mice. Mechanistically, Ribhigh-L.m. adherence to the gut epithelia upregulated fecal metabolites, among which lactate ranked as the top candidate. Excess lactate stimulated the epithelial production of serum amyloid A (SAA) in the gut via the GPR81-NFκB axis, contributing to peripheral Th1 activation. Moreover, GV-971 disrupted the adherence of Ribhigh-L.m. to gut epithelia via direct binding to Rib, which corrected the excess lactate, reduced SAA, and alleviated Th1-skewed inflammation. Together, we gained further insights into the molecular link between gut bacteria and AD progression and the mechanism of GV-971 in treating AD.
© 2024. The Author(s).
Conflict of interest statement
Figures
Similar articles
-
Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.Mol Neurodegener. 2024 Feb 17;19(1):18. doi: 10.1186/s13024-023-00700-w. Mol Neurodegener. 2024. PMID: 38365827 Free PMC article.
-
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression.Cell Res. 2019 Oct;29(10):787-803. doi: 10.1038/s41422-019-0216-x. Epub 2019 Sep 6. Cell Res. 2019. PMID: 31488882 Free PMC article.
-
Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer's disease mouse model.J Neuroinflammation. 2023 Nov 27;20(1):282. doi: 10.1186/s12974-023-02966-9. J Neuroinflammation. 2023. PMID: 38012646 Free PMC article.
-
Sodium Oligomannate: First Approval.Drugs. 2020 Mar;80(4):441-444. doi: 10.1007/s40265-020-01268-1. Drugs. 2020. PMID: 32020555 Review.
-
Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota.J Mol Med (Berl). 2023 Mar;101(3):201-222. doi: 10.1007/s00109-023-02289-5. Epub 2023 Feb 9. J Mol Med (Berl). 2023. PMID: 36757399 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials